Herbal Transdermal Patches for Rheumatoid Arthritis

All three formulations (F1, F2, and F3) have a consistent thickness of approximately 0.434 mm with minimal variation, indicating good control over the manufacturing process. The weight uniformity across the formulations is fairly consistent, with F1 (0.1850 gm), F2 (0.1866 gm), and F3 (0.1876 gm). The low standard deviations suggest uniform distribution of the patch components. F1 exhibits the highest folding endurance (15 ± 2.60), indicating superior flexibility and mechanical strength compared to F2 (12 ± 3.21) and F3 (13 ± 2.50). This suggests that F1 may be more durable during application and use. All formulations have a surface pH of 6, which is close to the skin's natural pH, suggesting that these patches are likely to be non-irritating and suitable for transdermal application. F1 has the highest moisture content (3.96 ± 0.86), followed by F2 (2.67 ± 0.50) and F3 (2.48 ± 0.31). Among the three formulations, F1 stands out due to its higher folding endurance and moisture content, which may contribute to better mechanical properties and comfort during use. However, all formulations exhibit acceptable thickness, weight uniformity, and surface pH, making them potentially suitable for transdermal applications. The development of a herbal transdermal patch utilizing Turmeric and Ginger extracts represents a promising alternative for the management of joint pain. This innovative approach leverages the well-documented anti-inflammatory and analgesic properties of these herbal extracts to provide effective pain relief. Future studies can focus on optimizing the extraction methods to yield higher concentrations of bioactive compounds, as well as refining the formulation to improve patch adhesion and wearability. Clinical trials will be essential to evaluate the efficacy and safety of the transdermal patch in a broader patient population.

1.                kinases by crude extract and pure compound isolated from Commiphora mukul leads to down regulation of TNF-α, IL-1β and IL-2. International Immunopharmacology 6(2):122-132. 2.                Ghulaxe C, Verma R (2015) A review on transdermal drug delivery system. The Pharma Innovation Journal 4(1): 37-43. 3.                Kirtikar KR, Basu BD, Singh B, Singh MP (1993) Indian Medicinal Plants. Dehra Dun, India 2nd (Edn.), 1: 490-491. 4.                Al-Nahain A, Jahan R, Rahmatullah M (2014) Zingiber officinale: A Potential Plant against Rheumatoid Arthritis. Arthritis 159089 pp: 8. 5.                Terry R, Posadzki P, Watson LK, Ernst E (2011) The Use of Ginger (Zingiber officinale) for the Treatment of Pain: A Systematic Review of Clinical Trials. Pain Medicine 12(12): 1808-1818. 6.                Abedinzade M, Nasri S, Omodi MJ, Ghasemi E, Ghorbani A (2015) Inflammatory Alterations Associated With Menopause. Iran Red Crescent Med J 17(11): e26685. 7.                Rasool M, Varalakshm V (2006) Suppressive effect of Withania somnifera root powder on experimental gouty arthritis. Chemico-Biological Interactions 164(3): 174-180. 8.                Fox LT, Gerber M, Plessis JD, Hamman JH (2011) Transdermal drug delivery enhancement by compounds of natural origin. Molecules 16(12): 10507-10540. 9.                Peach K, Tracey MV (1995) Modern Methods of Plant Analysis. Springer Science and Business Media pp: 23.